[Federal Register Volume 66, Number 76 (Thursday, April 19, 2001)]
[Notices]
[Page 20152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-9698]



[[Page 20152]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Advisory Committee to the Director, National Cancer Institute.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Advisory Committee to the Director, National 
Cancer Institute.
    Date: May 10, 2001.
    Time: 12 p.m. to 1 p.m.
    Agenda: To discuss the Leukemia, Lymphoma, and Myeloma Progress 
Review Group Report.
    Place: National Cancer Institute, National Institutes of Health, 
9000 Rockville Pike, Building 31, Room 11A03, Bethesda, MD 20892, 
(Telephone Conference Call).
    Contact Person: Susan J. Waldrop, Executive Secretary, National 
Institutes of Health, National Cancer Institute, Office of 
Scientific Opportunities, Bethesda, MD 20892, 301/496-1458.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/joint/htm, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)
    Dated: April 10, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-9698 Filed 4-18-01; 8:45 am]
BILLING CODE 4140-01-M